Precision Biotech Taiwan Corp.
2 clinical trials · Sponsor
◉ Watch Precision Biotech Taiwan Corp.
| Record | Firm | Date |
|---|---|---|
| Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients (NCT04616209) | Precision Biotech Taiwan Corp. | 2020-11-15 |
| An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer (NCT07271446) | Precision Biotech Taiwan Corp. | 2018-09-01 |
Track Precision Biotech Taiwan Corp. automatically
Every clearance here is in the API, with alerts when new ones post.